Stephen C. Harmer

CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy

Diogo Mosqueira, Ingra Mannhardt, Jamie R. Bhagwan et al. · European Heart Journal · 2018 · 242 citations · Full text

Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations

Ritika R. Kapoor, Sarah E. Flanagan, Chela James et al. · Diabetologia · 2011 · 92 citations · Full text

Metabolic Syndrome, Genetic Disorder, Genetics +7

Mechanisms of disease pathogenesis in long QT syndrome type 5

Stephen C. Harmer, Andrew J. Wilson, Robert W Aldridge et al. · American Journal of Physiology-Cell Physiology · 2009 · 49 citations · Full text

Cardiac Muscle, Genetics, Pathology +26

Characterization of a Binding Site for Anionic Phospholipids on KCNQ1

Alison Thomas, Stephen C. Harmer, Tapsi Khambra et al. · Journal of Biological Chemistry · 2010 · 48 citations · Full text

Human-based approaches to pharmacology and cardiology: an interdisciplinary and intersectorial workshop

Blanca Rodríguez, Annamaria Carusi, Najah Abi‐Gerges et al. · EP Europace · 2015 · 48 citations · Full text

Heart Failure, Engineering, Cardiovascular Pharmacology +22